세포 재생의료 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 14.4%로 826억 8,000만 달러로 성장합니다. 예측 기간 중의 성장은 홀리카 섹터의 재생의료 제품에 대한 수요 증가, 이식용 장기 부족, 연구개발 활동 증가, 유전자 치료에 대한 수요 증가에 기인하는 것으로 보입니다. 예측 기간 중 주요 동향으로는 첨단 치료, 임상시험 확대, 조직공학 및 3D 바이오프린팅, 엑소좀 기반 치료, 맞춤형 의료 등이 있습니다.
장기 이식의 광범위한 채택이 당분간 세포 재생 의료 시장의 성장을 촉진할 것으로 예상됩니다. 장기 이식은 손상되거나 결손된 장기를 대체하기 위해 개인의 신체에서 장기를 떼어내어 수혜자의 신체에 이식하는 의료 행위입니다. 이 의료 행위는 수명을 연장하고 투석과 같은 개입의 필요성을 줄일 수 있으므로 큰 인기를 얻고 있습니다. 세포 재생 의학은 손상된 조직과 장기의 복구 및 재생에 초점을 맞추어 장기 이식을 발전시킬 것으로 기대됩니다. 예를 들어 2023년 1월, 미국에 기반을 둔 과학 및 교육 구상 전문 기관인 United Network for Organ Sharing은 2022년 미국에서 약 42,887건의 장기 이식 수술이 이루어질 것으로 예상하고 있습니다.에 비해 3.7% 증가했습니다. 이에 따라 장기 이식의 광범위한 수용이 세포재생의료 시장의 원동력이 될 것으로 전망됩니다.
만성질환 증가는 향후 수년간 세포재생의료 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 3개월 이상 지속되는 질병으로 시간이 지남에 따라 악화되는 경향이 있습니다. 세포 재생 의학은 손상된 조직과 장기를 복구하고 젊어지게 하는 혁신적인 방법을 도입함으로써 만성질환 치료에 유망한 가능성을 제공하고, 만성질환 관리에 혁명을 가져올 수 있는 새로운 연구 및 치료 기회를 창출할 수 있습니다. 예를 들어 2024년 6월 정부 기관인 호주보건복지연구원은 만성질환으로 인한 연령표준화 사망률을 2020년 인구 10만 명당 448명, 2021년에는 459명, 2022년에는 490명, 2022년에는 490명이라고 보고했습니다. 이에 따라 만성질환의 부담 증가가 세포재생의료 시장의 성장에 박차를 가하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세포 재생의료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 세포 재생의료 시장 : 성장률 분석
- 세계의 세포 재생의료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세포 재생의료 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 세포 재생의료 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 세포 재생의료 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 치료제
- 툴
- 은행
- 서비스
- 세계의 세포 재생의료 시장 : 치료 카테고리별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 피부과
- 근골격
- 면역학과 염증
- 종양학
- 심장혈관
- 안과
- 기타 치료 카테고리
- 세계의 세포 재생의료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 상업 산업
- 정부 및 학술 조사기관
- 정부 및 학술 조사기관
- 세계의 세포 재생의료 시장, 치료제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 줄기세포 요법
- 유전자 치료
- 조직공학 제품
- 세계의 세포 재생의료 시장, 툴의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세포배양 장비
- 바이오리액터
- 이미징 시스템
- 세계의 세포 재생의료 시장, 은행의 유형별 서브 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 줄기세포 은행
- 조직은행
- 제대혈 은행
- 세계의 세포 재생의료 시장, 서비스의 유형별 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세포 처리 서비스
- 연구개발 서비스
- 임상시험 서비스
제7장 지역별·국가별 분석
- 세계의 세포 재생의료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세포 재생의료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세포 재생의료 시장 : 경쟁 구도
- 세포 재생의료 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- F.Hoffman-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Novartis AG
- Bristol-Myers Squibb Company
- Medtronic Plc
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Amgen Inc.
- ViaCord LLC
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Cook Biotech Inc.
- Integra LifeSciences Holdings Corporation
- NuVasive Inc.
- Organogenesis Holdings Inc.
- AMAG Pharmaceuticals Inc.
- Takara Bio Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 세포 재생의료 시장 2029 : 새로운 기회를 제공하는 국가
- 세포 재생의료 시장 2029 : 새로운 기회를 제공하는 부문
- 세포 재생의료 시장 2029 : 성장 전략
제36장 부록
KSA
Cell regeneration medicine is a field within medical science and technology that centers on harnessing the inherent capacity of cells to mend, replace, and regenerate damaged or ailing tissues and organs within the human body. This discipline employs diverse cellular therapies, tissue engineering techniques, and regenerative medicine strategies to facilitate healing and reinstate functionality to compromised areas.
The key components of cell regeneration medicine encompass therapeutics, tools, banks, and services. Therapeutics pertain to the medical treatment and care of patients with the objective of both preventing and managing diseases, alleviating pain or injury, and addressing conditions like injuries and diseases through methods such as immunomodulation therapy and tissue engineering. These therapeutics are classified into specific categories, including dermatology, musculoskeletal, immunology and inflammation, oncology, cardiovascular, ophthalmology, and others. They find application across various sectors, serving end-users like hospitals and clinics, commercial industries, government institutions, and academic research institutes.
The cell regeneration medicine research report is one of a series of new reports from The Business Research Company that provides cell regeneration medicine market statistics, including the cell regeneration medicine global market size, regional shares, competitors with a cell regeneration medicine market share, detailed cell regeneration medicine market segments, market trends and opportunities and any further data you may need to thrive in the cell regeneration medicine industry. This cell regeneration medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell regeneration medicine market size has grown rapidly in recent years. It will grow from $41.83 billion in 2024 to $48.25 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to aging population, prevalence of chronic diseases, growing government and corporate funding, growing demand for functional regenerative medicine products.
The cell regeneration medicine market size is expected to see rapid growth in the next few years. It will grow to $82.68 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising demand for regenerative medicine products from the horeca sector, shortage of organs for transplantation, increasing r&d activities, growing demand for gene therapies. Major trends in the forecast period include advanced therapies, clinical trial expansion, tissue engineering and 3d bioprinting, exosome-based therapies, personalized medicine.
The extensive adoption of organ transplantation is anticipated to drive the growth of the cell regeneration medicine market in the foreseeable future. Organ transplantation is a medical procedure involving the removal of an organ from one individual's body and its placement into the body of a recipient to replace a damaged or missing organ. This medical practice has gained significant popularity due to its ability to extend lives and reduce the need for interventions like dialysis. Cell regenerative medicine holds the promise of advancing organ transplantation by focusing on the repair and regeneration of damaged tissues or organs. For instance, in January 2023, as reported by the United Network for Organ Sharing, a US-based organization specializing in scientific and educational initiatives, the United States witnessed approximately 42,887 organ transplant procedures in 2022, marking a 3.7% increase compared to 2021. Consequently, the widespread acceptance of organ transplants is poised to be a driving force behind the cell regeneration medicine market.
The increasing prevalence of chronic diseases is expected to drive the growth of the cell regeneration medicine market in the coming years. Chronic diseases are illnesses that persist for three months or longer and tend to worsen over time. Cell regeneration medicine offers promising potential for treating chronic diseases by introducing innovative methods to repair and rejuvenate damaged tissues and organs, creating new opportunities for research and therapies that could revolutionize chronic disease management. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported an age-standardized death rate due to chronic conditions of 448 per 100,000 population in 2020, which rose to 459 per 100,000 in 2021, and further to 490 per 100,000 in 2022. Consequently, the increasing burden of chronic diseases is fueling the growth of the cell regeneration medicine market.
Leading companies in the cell regeneration medicine market are focusing on the development of medical-grade bioink to enhance their competitive position. Medical-grade bioink is a specialized ink designed for bioprinting that adheres to strict regulatory standards for safety and biocompatibility, making it ideal for use in tissue engineering, regenerative medicine, and creating biological structures for medical applications. For example, in October 2023, CELLINK, a Sweden-based company known for its innovations in cell regeneration medicine, introduced CELLINK Vivoink. This is the first medical-grade bioink created specifically for clinical applications in regenerative medicine and tissue engineering, optimized for exceptional printability, mechanical stability, and cell viability.
In April 2022, Metcela Inc., a Japanese biotechnology firm with expertise in heart disease treatment, completed the acquisition of Japan Regenerative Medicine Co. Ltd. (JRM) for an undisclosed sum. This acquisition provides Metcela with the opportunity to diversify and enhance its product development portfolio through the addition of JRM-001. This innovative product utilizes cardiac stem cells to facilitate the restoration of cardiac tissues, particularly for the treatment of heart diseases. Japan Regenerative Medicine Co. Ltd. (JRM) is a Japanese biotechnology company primarily focused on the development of regenerative medicine solutions for heart diseases.
Major companies operating in the cell regeneration medicine market are Pfizer Inc., Johnson & Johnson, F.Hoffman-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., ViaCord LLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Cook Biotech Inc., Integra LifeSciences Holdings Corporation, NuVasive Inc., Organogenesis Holdings Inc., AMAG Pharmaceuticals Inc., Takara Bio Inc., MiMedx Group Inc., Vericel Corporation, Mesoblast Limited, Osiris Therapeutics Inc., Guanhao Biotech Co. Ltd., CordLife Group Limited, FUJIFILM Cellular Dynamics Inc., Cesca Therapeutics Inc., U.S. Stem Cell Inc., Cytori Therapeutics Inc.
North America was the largest region in the cell regeneration medicine market in 2024. The regions covered in cell regeneration medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell regeneration medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell regeneration medicine market includes revenues earned by entities by providing stem cell treatments, cartilage regeneration, platelet-rich plasma and tissue engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell regeneration medicine market also includes of sales of various types of cell regeneration medicines, such as stem cells and progenitor cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Regeneration Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell regeneration medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell regeneration medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell regeneration medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Therapeutics; Tools; Banks; Services
- 2) By Therapeutic Category: Dermatology; Musculoskeletal; Immunology And Inflammation; Oncology; Cardiovascular; Ophthalmology; Other Therapeutic Categories
- 3) By End-User: Hospitals And Clinics; Commercial Industries; Government And Academic Research Institutes
- Subsegments:
- 1) By Therapeutics: Stem Cell Therapies; Gene Therapies; Tissue Engineering Products
- 2) By Tools: Cell Culture Equipment; Bioreactors; Imaging Systems
- 3) By Banks: Stem Cell Banks; Tissue Banks; Cord Blood Banks
- 4) By Services: Cell Processing Services; Research And Development Services; Clinical Trial Services
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F.Hoffman-La Roche Ltd.; AbbVie Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Regeneration Medicine Market Characteristics
3. Cell Regeneration Medicine Market Trends And Strategies
4. Cell Regeneration Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cell Regeneration Medicine Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cell Regeneration Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cell Regeneration Medicine Market Growth Rate Analysis
- 5.4. Global Cell Regeneration Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cell Regeneration Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cell Regeneration Medicine Total Addressable Market (TAM)
6. Cell Regeneration Medicine Market Segmentation
- 6.1. Global Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Therapeutics
- Tools
- Banks
- Services
- 6.2. Global Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dermatology
- Musculoskeletal
- Immunology And Inflammation
- Oncology
- Cardiovascular
- Ophthalmology
- Other Therapeutic Categories
- 6.3. Global Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Commercial Industries
- Government And Academic Research Institutes
- Government And Academic Research Institutes
- 6.4. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stem Cell Therapies
- Gene Therapies
- Tissue Engineering Products
- 6.5. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Culture Equipment
- Bioreactors
- Imaging Systems
- 6.6. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Banks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stem Cell Banks
- Tissue Banks
- Cord Blood Banks
- 6.7. Global Cell Regeneration Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Processing Services
- Research And Development Services
- Clinical Trial Services
7. Cell Regeneration Medicine Market Regional And Country Analysis
- 7.1. Global Cell Regeneration Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cell Regeneration Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cell Regeneration Medicine Market
- 8.1. Asia-Pacific Cell Regeneration Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cell Regeneration Medicine Market
- 9.1. China Cell Regeneration Medicine Market Overview
- 9.2. China Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cell Regeneration Medicine Market
- 10.1. India Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cell Regeneration Medicine Market
- 11.1. Japan Cell Regeneration Medicine Market Overview
- 11.2. Japan Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cell Regeneration Medicine Market
- 12.1. Australia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cell Regeneration Medicine Market
- 13.1. Indonesia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cell Regeneration Medicine Market
- 14.1. South Korea Cell Regeneration Medicine Market Overview
- 14.2. South Korea Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cell Regeneration Medicine Market
- 15.1. Western Europe Cell Regeneration Medicine Market Overview
- 15.2. Western Europe Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cell Regeneration Medicine Market
- 16.1. UK Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cell Regeneration Medicine Market
- 17.1. Germany Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cell Regeneration Medicine Market
- 18.1. France Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cell Regeneration Medicine Market
- 19.1. Italy Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cell Regeneration Medicine Market
- 20.1. Spain Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cell Regeneration Medicine Market
- 21.1. Eastern Europe Cell Regeneration Medicine Market Overview
- 21.2. Eastern Europe Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cell Regeneration Medicine Market
- 22.1. Russia Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cell Regeneration Medicine Market
- 23.1. North America Cell Regeneration Medicine Market Overview
- 23.2. North America Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cell Regeneration Medicine Market
- 24.1. USA Cell Regeneration Medicine Market Overview
- 24.2. USA Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cell Regeneration Medicine Market
- 25.1. Canada Cell Regeneration Medicine Market Overview
- 25.2. Canada Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cell Regeneration Medicine Market
- 26.1. South America Cell Regeneration Medicine Market Overview
- 26.2. South America Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cell Regeneration Medicine Market
- 27.1. Brazil Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cell Regeneration Medicine Market
- 28.1. Middle East Cell Regeneration Medicine Market Overview
- 28.2. Middle East Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cell Regeneration Medicine Market
- 29.1. Africa Cell Regeneration Medicine Market Overview
- 29.2. Africa Cell Regeneration Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cell Regeneration Medicine Market, Segmentation By Therapeutic Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cell Regeneration Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cell Regeneration Medicine Market Competitive Landscape And Company Profiles
- 30.1. Cell Regeneration Medicine Market Competitive Landscape
- 30.2. Cell Regeneration Medicine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F.Hoffman-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Cell Regeneration Medicine Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Bristol-Myers Squibb Company
- 31.3. Medtronic Plc
- 31.4. Eli Lilly and Company
- 31.5. Boehringer Ingelheim International GmbH
- 31.6. Amgen Inc.
- 31.7. ViaCord LLC
- 31.8. Stryker Corporation
- 31.9. Zimmer Biomet Holdings Inc.
- 31.10. Cook Biotech Inc.
- 31.11. Integra LifeSciences Holdings Corporation
- 31.12. NuVasive Inc.
- 31.13. Organogenesis Holdings Inc.
- 31.14. AMAG Pharmaceuticals Inc.
- 31.15. Takara Bio Inc.
32. Global Cell Regeneration Medicine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cell Regeneration Medicine Market
34. Recent Developments In The Cell Regeneration Medicine Market
35. Cell Regeneration Medicine Market High Potential Countries, Segments and Strategies
- 35.1 Cell Regeneration Medicine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cell Regeneration Medicine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cell Regeneration Medicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
